Phase 3, Open-Label, Randomized, Multi-Center Study of DZD9008 versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertion Mutation
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
CTRC Inpatient
Lone Tree Medical Center
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
![Photograph of Ross Camidge](https://som.ucdenver.edu/FIMS/Content/faculty/18871/CU-Doctors-18871.jpg)
Ross Camidge
Study ID
Protocol Number: 23-0488
More information available at ClinicalTrials.gov: NCT05668988
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers